Update on the Role of C1GALT1 in Cancer

Overview

Journal Oncol Lett

Specialty Oncology

Date 2022 Feb 14

PMID 35154428

Authors

Tong Xia

Ting Xiang

Hailong Xie

Affiliations

Soon will be listed here.

Abstract

Cancer remains one of the most difficult diseases to treat. In the quest for early diagnoses to improve patient survival and prognosis, targeted therapies have become a hot research topic in recent years. Glycosylation is the most common posttranslational modification in mammalian cells. Core 1β1,3-galactosyltransferase (C1GALT1) is a key glycosyltransferase in the glycosylation process and is the key enzyme in the formation of the core 1 structure on which most complex and branched O-glycans are formed. A recent study reported that C1GALT1 was aberrantly expressed in tumors. In cancer cells, C1GALT1 is regulated by different factors. In the present review, the expression of C1GALT1 in different tumors and its possible molecular mechanisms of action are described and the role of C1GALT1 in cancer development is discussed.

Citing Articles

C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter-mediated doxorubicin resistance.

Liu C, Huang J, Chang H, Chen C, Tsai Y, Chen W J Pathol. 2025; 265(3):289-301.

PMID: 39844613 PMC: 11794964. DOI: 10.1002/path.6384.

GeniePool 2.0: advancing variant analysis through CHM13-T2T, AlphaMissense, gnomAD V4 integration, and variant co-occurrence queries.

Weintraub G, Hadar N, Gudes E, Dolev S, Birk O Database (Oxford). 2024; 2024.

PMID: 39729312 PMC: 11673193. DOI: 10.1093/database/baae130.

Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression.

Tian H, Yu J, Chu X, Guan Q, Liu J, Liu Y Front Oncol. 2024; 14:1389713.

PMID: 38699634 PMC: 11063370. DOI: 10.3389/fonc.2024.1389713.

High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.

Chen Y, Ji Y, Shen L, Li Y, Ren Y, Shi H J Cancer Res Clin Oncol. 2024; 150(4):214.

PMID: 38662050 PMC: 11045595. DOI: 10.1007/s00432-024-05745-y.

Molecular cloning, characterisation and molecular modelling of two novel T-synthases from mollusc origin.

Zemkollari M, Oostenbrink C, Grabherr R, Staudacher E Glycobiology. 2024; 34(4).

PMID: 38366999 PMC: 11005171. DOI: 10.1093/glycob/cwae013.

References

Marcucci F, Bellone M, Caserta C, Corti A . Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads. Int J Cancer. 2013; 135(6):1265-76. DOI: 10.1002/ijc.28572. View

Kaposi-Novak P, Lee J, Gomez-Quiroz L, Coulouarn C, Factor V, Thorgeirsson S . Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest. 2006; 116(6):1582-95. PMC: 1462944. DOI: 10.1172/JCI27236. View

Ju T, Cummings R, Canfield W . Purification, characterization, and subunit structure of rat core 1 Beta1,3-galactosyltransferase. J Biol Chem. 2001; 277(1):169-77. DOI: 10.1074/jbc.M109056200. View

Chen L, Zhang D, Ding T, Liu F, Xu X, Tian Y . LncRNA NR2F2-AS1 Upregulates Rac1 to Increase Cancer Stemness in Clear Cell Renal Cell Carcinoma. Cancer Biother Radiopharm. 2020; 35(4):301-306. DOI: 10.1089/cbr.2019.3319. View

DErrico A, Fiorentino M, Ponzetto A, Daikuhara Y, Tsubouchi H, Brechot C . Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does. Hepatology. 1996; 24(1):60-4. DOI: 10.1002/hep.510240112. View

Huang M, Hu R, Chou C, Hsu C, Liu Y, Huang J . Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling. Oncotarget. 2015; 6(8):5650-65. PMC: 4467392. DOI: 10.18632/oncotarget.3117. View

Alexander W, Viney E, Zhang J, Metcalf D, Kauppi M, Hyland C . Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene. Proc Natl Acad Sci U S A. 2006; 103(44):16442-7. PMC: 1637601. DOI: 10.1073/pnas.0607872103. View

Wu Y, Liu C, Huang M, Lai H, Lee P, Hu R . C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Cancer Res. 2013; 73(17):5580-90. DOI: 10.1158/0008-5472.CAN-13-0869. View

Kufe D . Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009; 9(12):874-85. PMC: 2951677. DOI: 10.1038/nrc2761. View

10.

Dong X, Chen C, Deng X, Liu Y, Duan Q, Peng Z . A novel mechanism for C1GALT1 in the regulation of gastric cancer progression. Cell Biosci. 2021; 11(1):166. PMC: 8393437. DOI: 10.1186/s13578-021-00678-2. View

11.

Qian L, Mizumoto K, Urashima T, Nagai E, Maehara N, Sato N . Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res. 2002; 8(4):1223-7. View

12.

Wu J, Li Y, Dang Y, Gao H, Jiang J, Chen Z . HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling. Mol Cancer Ther. 2014; 14(2):553-63. DOI: 10.1158/1535-7163.MCT-14-0618. View

13.

Chou C, Huang M, Liao Y, Chen C, Huang M . C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer. Int J Gynecol Cancer. 2017; 27(5):863-871. DOI: 10.1097/IGC.0000000000000965. View

14.

Gao N, Bergstrom K, Fu J, Xie B, Chen W, Xia L . Loss of intestinal O-glycans promotes spontaneous duodenal tumors. Am J Physiol Gastrointest Liver Physiol. 2016; 311(1):G74-83. PMC: 4967177. DOI: 10.1152/ajpgi.00060.2016. View

15.

Dong X, Luo Z, Wang Y, Meng L, Duan Q, Qiu L . Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma. Exp Cell Res. 2017; 362(2):302-310. DOI: 10.1016/j.yexcr.2017.11.031. View

16.

Mueller M, Fusenig N . Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004; 4(11):839-49. DOI: 10.1038/nrc1477. View

17.

Kazanietz M, Caloca M . The Rac GTPase in Cancer: From Old Concepts to New Paradigms. Cancer Res. 2017; 77(20):5445-5451. PMC: 5645227. DOI: 10.1158/0008-5472.CAN-17-1456. View

18.

Aftab B, Dobromilskaya I, Liu J, Rudin C . Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. Cancer Res. 2011; 71(21):6764-72. PMC: 3206167. DOI: 10.1158/0008-5472.CAN-11-0691. View

19.

Karsten U, Goletz S . What controls the expression of the core-1 (Thomsen-Friedenreich) glycotope on tumor cells?. Biochemistry (Mosc). 2015; 80(7):801-7. DOI: 10.1134/S0006297915070019. View

20.

Boyd A, Bartlett P, Lackmann M . Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov. 2014; 13(1):39-62. DOI: 10.1038/nrd4175. View